First Oral Treatment for CKD Anemia OK'd for Patients on Dialysis

(MedPage Today) -- The FDA approved the first oral agent for chronic kidney disease (CKD)-related anemia for adults on dialysis, the agency announced late on Wednesday. Daprodustat (Jesduvroq) is a once-daily tablet specifically indicated for...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news